Intranuclear localization and isoform-dependent translocation of 14-3-3 proteins in human brain with infarction

Journal of the Neurological Sciences

Volumn 260, Issue 1-2, 2007, Pages 159-166

  Umahara, Takahiko ^a,b   Uchihara, Toshiki ^b   Tsuchiya, Kuniaki ^c   Nakamura, Ayako ^b   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

14 3 3 proteins; Apoptosis; Brain infarction; Ischemic penumbra; Isoform dependent translocation; Neuronal nucleus

Indexed keywords

ISOPROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 SIGMA; PROTEIN 14 3 3 ZETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN INFARCTION; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; MALE; NERVE CELL; NEUROPROTECTION; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; WHITE MATTER;

14-3-3 PROTEINS; ACTIVE TRANSPORT, CELL NUCLEUS; AGED; AGED, 80 AND OVER; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL NUCLEUS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEURONS; OLIGODENDROGLIA; PROTEIN ISOFORMS;

EID: 34547657218     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.04.053     Document Type: Article

References (32)

1. Aitken A., Colling D.B., van Heusden B.P., Isobe T., Roseboon P.H., Rosenfeld G., et al. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 17 (1992) 498-501
2. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 16 (2006) 162-172
3. Skoulakis E.M.C., and Davis R.L. 14-3-3 proteins in neuronal development and function. Mol Neurobiol 16 (1998) 269-284
4. Tzivion G., and Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 14 (2001) 3061-3064
5. Berg D., Holzmann C., and Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4 (2003) 752-762
6. Dougherty M.K., and Morrison D.K. Unlocking the code of 14-3-3. J Cell Sci 117 (2004) 1875-1884
7. Mhawech P. 14-3-3 proteins-an update. Cell Res 15 (2005) 228-236
8. Pan S., Sehnke P.C., Ferl R.J., and Gurley W.B. Specific interactions with TBP and TFIIB in vitro suggest that 14-3-3 proteins may participate in the regulation of transcription when part of a DNA binding complex. Plant Cell 11 (1999) 1591-1602
9. Grozinger C.M., and Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A 97 (2000) 7835-7840
10. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-692
11. Brunet A., Kanai F., Stehn J., Stehn J., Xu J., Sarbassova D., et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 156 (2002) 817-828
12. Chen X.O., Fung Y.-W.W., and Yu A.C.H. Association of 14-3-3 γ and phosphorylated bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metab 25 (2005) 338-347
13. Layfield R., Fergusson J., Aitken A., Lowe J., and Landon L. Neurofibrillary tangles of Alzheimer's disease brain contain 14-3-3 protein. Neurosci Lett 209 (1996) 57-60
14. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., et al. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol 108 (2004) 279-286
15. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., et al. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci Lett 371 (2004) 215-219
16. Kawamoto Y., Akiguchi I., Nakamura S., Honjyo Y., Shibasaki H., and Budka H. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brain. J Neuropathol Exp Neurol 61 (2002) 245-253
17. Martin H., Rostas J., Patel Y., and Aitken. Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63 (1994) 2259-2265
18. Wakabayashi H., Yano M., Tachikawa N., Oka S., Maeda M., and Kido H. Increased concentration of 14-3-3 epsilon, gamma, and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. Clin Chim Acta 312 (2001) 97-105
19. Baxter H.C., Liu W.G., and Forster J.L. Immunolocalization of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 109 (2002) 5-14
20. van Hemert M.J., Niemantsverdriet M., Schmidt T., Backendorf C., and Spaink H.P. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J Cell Sci 117 (2004) 1411-1420
21. Gao Y., Signore A.P., Yin W., Cao G., Yin X.-.M., Sun F., et al. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 25 (2005) 694-712
22. Pirim I. Ischemic rat brains contain immunoreactivity of 14-3-3 proteins. Int J Neurosci 95 (1998) 101-106
23. Saito A., Hayashi T., Okuno S., Ferrand-Drake M., and Chan P.H. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against ischemia by blocking activation of the bad cell death signaling pathway. J Neurosci 23 (2003) 1710-1718
24. Saito A., Narasimhan P., Hayashi T., Okuno S., Ferrand-Drake M., and Chan P.H. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 24 (2004) 1584-1593
25. Kawamoto Y., Akiguchi I., Tomimoto H., Shirakashi, Honjyo Y., and Budka H. Upregulated expression of 14-3-3 proteins in astrocytes from human cerebrovascular ischemic lesions. Stroke 37 (2006) 830-835
26. Aure R.N., and Sutherland G.R. Dark neurons. Chapter 5; Hypoxia and related conditions. In: Graham D.I., and Lantos P.L. (Eds). Greenfields Neuropathology. 7th edn (2002), Arnold, London 254-256
27. Umahara T., Uchihara T., Yagishita S., Nakamura A., Tsuchiya K., and Iwamoto T. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Neurosci Lett 414 (2007) 130-135
28. Kawamoto Y., Akiguchi I., Kovacs G.G., Flicker H., and Budka H. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis. Acta Neuropathol 107 (2004) 137-143
29. Tanaka K. Alternation of second messengers during acute cerebral ischemia-adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein. Prog Neurobiol 65 (2001) 173-207
30. Screaton R.A., Conkright M.D., Katho Y., Best J.L., Canettieri G., Jeffries S., et al. The CREB coactivator TORC2 functions as calcium- and cAMP-sensitive coincidence detector. Cell 119 (2004) 61-74
31. Charriaut-Marlangue C., Maragaill I., Represa A., Popovici T., Plotkine M., and Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Metab 16 (1996) 186-195
32. Sairanen T., Karjalainen-Lindsberg M.L., Paetau A., Ijas P., and Lindsberg PJ. Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain 129 (2006) 189-199